Cargando…

Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials

BACKGROUNDS: The aim of this study is investigating the benefits and harms of neuromuscular blocking agents (NMBAs) in patients with acute respiratory distress syndrome (ARDS). METHODS: We comprehensively searched PubMed, EMBASE, and Cochrane library for randomized controlled trials comparing NMBAs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Zhongjun, Jiang, Libing, Zhang, Song, Guervilly, Christophe, Zhang, Mao, Feng, Xia, Ding, Jianbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958940/ https://www.ncbi.nlm.nih.gov/pubmed/31931794 http://dx.doi.org/10.1186/s12931-020-1287-4

Ejemplares similares

Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials
por: Tarazan, Nehal, et al.
Publicado: (2020)

Role of Neuromuscular Blocking Agents in Acute Respiratory Distress Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials
por: Wei, Xue-biao, et al.
Publicado: (2020)

Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials
por: Ho, An Thi Nhat, et al.
Publicado: (2020)

Neuromuscular blocking agents for acute respiratory distress syndrome
por: Torbic, Heather, et al.
Publicado: (2019)

Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials
por: Chang, Wei, et al.
Publicado: (2020)

Is it appropriate for acute respiratory distress syndrome patients with neuromuscular blocking agents?
por: Tan, Zhimin, et al.
Publicado: (2023)

Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials
por: Alhazzani, Waleed, et al.
Publicado: (2013)

Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression
por: Shao, Shuai, et al.
Publicado: (2020)

Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?
por: Torbic, Heather, et al.
Publicado: (2019)

Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials
por: Pereira, VGM
Publicado: (2013)

Neuromuscular blocking agents in patients with acute respiratory distress syndrome: a summary of the current evidence from three randomized controlled trials
por: Neto, Ary Serpa, et al.
Publicado: (2012)

Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study
por: Courcelle, Romain, et al.
Publicado: (2020)

The Implementation of Protocol-Based Utilization of Neuromuscular Blocking Agent Using Clinical Variables in Acute Respiratory Distress Syndrome Patients
por: Hadique, Sarah, et al.
Publicado: (2021)

Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis
por: Hua, Yusi, et al.
Publicado: (2020)

Flexible organic frameworks sequester neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo
por: Wu, Yan, et al.
Publicado: (2022)

Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents
por: Higashi, Michiko, et al.
Publicado: (2019)

Update on the management of neuromuscular block: focus on sugammadex
por: de Boer, Hans D, et al.
Publicado: (2007)

Neuromuscular blocking agents in the intensive care unit
por: Rodríguez-Blanco, Jonathan, et al.
Publicado: (2022)

Tracheal Intubation Without the Use of Neuromuscular Blocking Agents
por: Prakash, Smita
Publicado: (2012)

Assessment of Airway Closure and Expiratory Airflow Limitation to Set Positive End-Expiratory Pressure in Morbidly Obese Patients with Acute Respiratory Distress Syndrome
por: Mezidi, Mehdi, et al.
Publicado: (2021)

Neuromuscular Blocking Agents and Monitoring in China: A Cross-Sectional Survey of Current Management
por: Wu, HaoTian, et al.
Publicado: (2022)

Effect of high-frequency oscillatory ventilation on esophageal and transpulmonary pressures in moderate-to-severe acute respiratory distress syndrome
por: Guervilly, Christophe, et al.
Publicado: (2016)

Urgent intubation without neuromuscular blocking agents and the risk of tracheostomy
por: Fujinaga, Jun, et al.
Publicado: (2019)

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
por: Honore, Patrick M., et al.
Publicado: (2020)

High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndrome
por: Guervilly, Christophe, et al.
Publicado: (2011)

Update in acute respiratory distress syndrome
por: Koh, Younsuck
Publicado: (2014)

Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent
por: Zhang, Xiangjun, et al.
Publicado: (2019)

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
por: Schaller, Stefan Josef, et al.
Publicado: (2013)

Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
por: Kim, Yong Byum, et al.
Publicado: (2017)

Potential cross-allergic reaction from pholcodine and neuromuscular blocking agents
Publicado: (2022)

Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications
por: Cho, Sung-Ae, et al.
Publicado: (2022)

Residual neuromuscular block in the postanesthesia care unit: incidence, risk factors, and effect of neuromuscular monitoring and reversal agents
por: ÖZBEY, Nazlı Bahar, et al.
Publicado: (2022)

Albumin versus Other Fluids for Fluid Resuscitation in Patients with Sepsis: A Meta-Analysis
por: Jiang, Libing, et al.
Publicado: (2014)

Reversal of neuromuscular block
por: Bhalotra, Anju Romina
Publicado: (2018)

Acute Respiratory Distress Syndrome: An Update and Review
por: Rawal, Gautam, et al.
Publicado: (2018)

Effects of pretreatment with different neuromuscular blocking agents on facilitation of intubation with rocuronium: A prospective randomized comparative study
por: Shashank, DS, et al.
Publicado: (2014)

Threshold for basophil activation test positivity in neuromuscular blocking agents hypersensitivity reactions
por: Hagau, Natalia, et al.
Publicado: (2013)

Endotracheal Intubation Without Neuromuscular Blocking Agents: Is It a Good and Safe Option?
por: Akan, Mert, et al.
Publicado: (2012)

Erratum: Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents
por: Kim, Yong Beom, et al.
Publicado: (2017)

Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey
por: Kim, Jin Sun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ohd72vpjrgkc1lpjpdefa5mn4l